As the Bloomberg Distinguished Professor of Infectious Disease Dynamics, Cummings will investigate the transmission of diseases to develop interventions
Hopkins expert Thomas Hartung discusses NIH announcement that it will no longer consider grant proposals that do not include alternative testing models
JHU's Neurofibromatosis Therapeutic Acceleration Program celebrated the 10th anniversary of its Francis S. Collins Scholars Program, an initiative that has led to research and treatment breakthroughs for the genetic condition neurofibromatosis type 1
Researchers like Richard Huganir are closing in on a cure for SYNGAP1-related disorders. But in the face of federal funding cuts, can they finish what they started?
/ Johns Hopkins Magazine
At Johns Hopkins Hospital, music therapists use stirring rhythms and soothing melodies to support patients and their families during the hardest moments of their lives
/ Johns Hopkins Magazine
Federal budget cuts have created "a climate of anxiety" among medical researchers, says Maximilian F. Konig, a rheumatologist at Johns Hopkins. But those who live with autoimmune diseases could suffer the greatest consequences.